BAX and neoplasm: Following five daily i.p doses of 80mg/kg 17-AAG to athymic mice bearing isogenic HCT116 BAX+/− or HCT116 BAX−/− human colon cancer xenografts, a clear effect on the growth of both tumor models was observed.